Chuangshiji Biotechnology

CreatiPhage, based in Shanghai's Xinzhuang Industrial Zone, is a biotech company focused on addressing antibiotic resistance through the development of bacteriophage technology. Bacteriophages, or phages, are viruses that specifically target and infect bacteria, offering a promising alternative to traditional antibiotics. The company operates in the healthcare and pharmaceutical market, primarily serving medical institutions and research organizations. CreatiPhage's business model revolves around the research, development, and commercialization of high-performance lytic phages, which are designed to combat bacterial infections such as those caused by Acinetobacter baumannii. Revenue is generated through partnerships, licensing agreements, and direct sales of their phage products. Recognized as an innovative SME by the Shanghai Municipal Commission of Economy and Informatization, CreatiPhage is noted for its specialization and growth potential in the biotech sector. The company actively engages with experts and scholars in the field to enhance its research capabilities and expand its market reach. Keywords: bacteriophage, antibiotic resistance, biotech, healthcare, pharmaceutical, lytic phages, Acinetobacter baumannii, commercialization, SME, Shanghai.